MSKCC Update in Hematology and Medical Oncology 2026

MSKCC Update in Hematology and Medical Oncology 2026

Comprehensive Cancer Management & Board Review

📦 Product Details

• Listed MedicalAmboss package: 47 Videos + 47 Subtitles (.vtt) + 49 PDFs
• Total Size: 15.81 GB
• Course Date: March 13–16, 2026
• Access: On-demand
• Level: Advanced / Board Review

🧬 Program Overview

The MSKCC Update in Hematology and Medical Oncology 2026 (14th Annual Board Review) is a comprehensive, high-yield course covering the full spectrum of solid tumors and hematologic malignancies.

Designed for practicing clinicians and trainees, this program delivers state-of-the-art updates in diagnosis, staging, and treatment, along with practical insights to support both clinical decision-making and board exam preparation.

With expert-led lectures from one of the world’s leading cancer centers, this course reviews rapidly evolving oncology therapies and standards of care.

🎯 Key Features

• Expert-led lectures across oncology subspecialties
• Comprehensive coverage of solid tumors + hematologic malignancies
• Includes board-style review and post-test preparation
• Case-based and evidence-based teaching approach
• Subtitles + downloadable PDFs for flexible learning

📚 What You Will Learn

• Apply current standards in diagnosis, staging, and treatment of cancers
• Integrate latest therapies (targeted, immunotherapy, CAR-T) into practice
• Manage complex hematologic disorders and malignancies
• Understand oncology pharmacology and treatment strategies
• Prepare effectively for ABIM Hematology & Oncology board exams

🧩 Core Topics Covered

🧪 Hematologic Malignancies

• Acute lymphocytic leukemia (ALL)
• Acute myeloid leukemia (AML)
• Chronic lymphocytic leukemia (CLL)
• Chronic myelogenous leukemia (CML)
• Hodgkin & non-Hodgkin lymphoma
• Multiple myeloma & amyloidosis
• Myelodysplastic syndromes & myeloproliferative neoplasms

🩸 Benign Hematology

• Anemia & hemolytic disorders
• Thrombocytopenia & ITP
• Thrombotic disorders
• Transfusion medicine & complications

🎗️ Solid Tumor Oncology

• Breast cancer (HER2+, hormone-positive, triple-negative)
• Lung cancer (NSCLC & small cell)
• Gastrointestinal cancers (colon, gastric, pancreatic)
• Genitourinary cancers (prostate, kidney, urothelial)
• Gynecologic cancers (ovarian, cervical, uterine)
• Head & neck cancers
• CNS tumors & melanoma
• Sarcoma & rare tumors

⚙️ Advanced Oncology Topics

• CAR-T cell therapy
• Cancer genetics & hereditary syndromes
• Oncology pharmacology
• Anticoagulation in cancer
• Infectious complications in oncology

🧠 Learning Approach

• Evidence-based lectures
• Case-oriented discussions
• Board-focused review sessions
• Practical clinical insights from experts

👨‍⚕️ Target Audience

• Medical oncologists
• Hematologists
• Oncology fellows and residents
• Nurse practitioners & physician assistants
• Pharmacists and oncology care providers

🚀 Why This Course Stands Out

• Covers entire oncology spectrum in one course
• Strong focus on both clinical practice + board exam prep
• Includes latest advances in cancer therapy (2026 updates)
• Delivered by experts from MSKCC – global leader in oncology
• Ideal for updating knowledge and exam readiness simultaneously

4. Topics

1. Acute Lymphocytic Leukemia

2. Acute Myeloid Leukemia

3. Anal and Rectal Cancers

4. Anticoagulation- Update on an Evolving Field

5. Approach to the Bleeding Patient

6. Auto _Allo

7. Breast Cancer- Radiation Therapy

8. Breast Cancer- Surgery

9. CAR T Cell

10. Carcinoma of Unknown Primary

11. Central Nervous System Tumors

12. Chronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma

13. Chronic Myelogenous Leukemia

14. Clinical Indications for Use of Blood Products and Associated Risks

15. Colon Cancer

16. Diffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma

17. Esophageal and Gastric Cancers

18. Head and Neck, Thyroid, and Non-Melanoma Skin Cancers

19. Hemolytic Anemia

20. Hepatocellular Cancer and Cholangiocarcinoma

21. HER2-Positive Breast Cancer

22. Hereditary Cancer Genetics

23. Hodgkin Lymphoma_T Cell

24. Hormone Receptor-Positive Breast Cancer

25. Infectious Disease

26. Kidney Cancer

27. Low-Grade Non-Hodgkin Lymphoma

28. Melanoma

29. Mesothelioma

30. Myelodysplastic

31. Myeloma_Amyloid

32. Myeloproliferative Neoplasms

33. Non-Small Cell Lung Cancer

34. Ovarian Cancer

35. Pancreatic and Neuroendocrine Cancers

36. Pharmacology I_II

37. Prostate Cancer

38. Sarcoma

39. Sickle Cell Disease, Thalassemia

40. Small Cell Lung Cancer

41. Testis Cancer

42. Thrombocytopenia and ITP

43. Thrombotic Disorders

44. Transfusion Reactions

45. Triple-Negative Breast Cancer

46. Urothelial Cancer

47. Uterine, Cervix, and Other Gynecologic Cancers

48. 2026 Post-Test HemOnc Board Review